United States politician Rep. Marjorie Taylor Greene is continuing her stock purchases despite ongoing controversy over her trades.

In her latest filing on August 29, 2025, the lawmaker disclosed buying shares in at least a dozen companies a day earlier. The transactions ranged from $1,001 to $50,000 and covered sectors including technology, healthcare, logistics, and utilities.

Her purchases included Exelon, FedEx, Alphabet, MercadoLibre, Merck, Morgan Stanley, Novo Nordisk, PepsiCo, Ryman Hospitality Properties, Southern Company, UnitedHealth Group, and United Parcel Service.

These trades come against the backdrop of earlier scrutiny of Greene’s investment activity. For instance, in April, she reported purchases worth between $21,000 and $315,000 across nearly 20 companies just as markets reacted to President Donald Trump’s “Liberation Day” tariff announcement.

That round of Congress trades included Apple, Amazon, Nvidia, and Palantir, firms directly affected by shifts in trade and security policy.

Greene’s suspicious purchases 

Particular attention centered on her acquisition of up to $30,000 in Palantir shares shortly before the company secured a $30 million contract with U.S. Immigration and Customs Enforcement. Her stake in the software firm remains one of her most lucrative investments of 2025.

Overall, the sizable gains from her “Liberation Day” trades fueled criticism that she may have acted on insider knowledge, especially after equities rallied when the president announced a pause to the tariffs.

She also disclosed selling up to $100,000 in U.S. Treasury bills, drawing further accusations from Democrats and watchdog groups.

Interestingly, Greene has denied wrongdoing, insisting a financial adviser manages her investments under a fiduciary agreement.

Featured image via Shutterstock